The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Experimental and Therapeutic Medicine
Open accessAbstract
Abstract. Cancer cachexia occurs in the majority of cancer patients before death, and it is responsible for the death of 22% of cancer patients. One of the most relevant characteristics of cachexia is that of asthenia, which reflects significant muscle wasting noted in cachectic cancer patients The aim of the present study was to assess whether the β2-adrenergic agonist formoterol is associated with an improvement in physiological parameters such as grip force and total physical activity in cachetic rats. Administration of the β2-agonist formoterol (0.3 mg/kg for 7 days) in rats bearing Yoshida AH-130 ascites hepatoma tumors, a model which induces a strong loss of both body and muscle weight, resulted in a significant reversal of the muscle wasting process, as reflected by individual muscle weights. The anti-wasting effects of the drug were also observed in terms of total physical activity and grip force, thus resulting in an improvement in physical performance in cachectic tumor-bearing rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mersmann, H. J. (1998) · Journal of Animal Science · doi:10.2527/1998.761160x · Cited by 475
THE IMMEDIATE CAUSES OF DEATH IN CANCER
WARREN, S. (1932) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193211000-00002 · Cited by 424
The role of cytokines in cancer cachexia
Argilés, J. M., Busquets, S., Toledo, M., & López-Soriano, F. J. (2009) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e3283311d09 · Cited by 211
Nutritional assessment and patient outcome during oncological therapy
Harvey, K. B., Bothe, A., & Blackburn, G. L. (1979) · Cancer · Cited by 145
Costelli, P., Garcia‐Martínez, C., Llovera, M., Carbó, N., López-Soriano, F. J., Agell, N., Tessitore, L., Baccino, F. M., & Argilés, J. M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117929 · Cited by 142
Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals
Tessitore, L., Costelli, P., Bonetti, G., & Baccino, F. M. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1479 · Cited by 126
Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice
Llovera, M., Garcia‐Martínez, C., López‐Soriano, J., Carbó, N., Agell, N., López-Soriano, F. J., & Argilés, J. M. A. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00105-1 · Cited by 120
DNA Fragmentation Occurs in Skeletal Muscle during Tumor Growth: A Link with Cancer Cachexia?
van Royen, M. E., Carbó, N., Busquets, S., Alvarez, B., Quinn, L. S., López-Soriano, F. J., & Argilés, J. M. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2462 · Cited by 101
The role of cytokines in muscle wasting: Its relation with cancer cachexia
Argilés, J. M. A., Garcia‐Martínez, C., Llovera, M., & López-Soriano, F. J. (1992) · Medicinal Research Reviews · doi:10.1002/med.2610120605 · Cited by 78
Zangarelli, A., Chanséaume, E., Morio, B., Malpuech‐Brugère, C., Mosoni, L., Rousset, P., Giraudet, C., Patrac, V., Gachon, P., Boirie, Y., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4544com · Cited by 76
Cytokines as Mediators and Targets for Cancer Cachexia
Argilés, J. M. A., Busquets, S., & López-Soriano, F. J. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_9 · Cited by 67
Rajab, P., Fox, J., Riaz, S. S., Tomlinson, D. R., Ball, D., & Greenhaff, P. L. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.3.r1076 · Cited by 65
Why do cancer cells have such a high glycolytic rate?
Argilés, J. M. A., & López-Soriano, F. J. (1990) · Medical Hypotheses · doi:10.1016/0306-9877(90)90039-h · Cited by 59
Signorile, J. F., Banovac, K., Gómez, M. F. L., Flipse, D., Caruso, J. F., & Lowensteyn, I. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)80043-3 · Cited by 51
Cancer cachexia: Physical activity and muscle force in tumour-bearing rats
Argilés (2010) · Oncology Reports · doi:10.3892/or_00001060 · Cited by 47
Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone
Agbenyega, E. T., & Wareham, A. C. (1992) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(92)90026-m · Cited by 42
Muscle-Specific Effects of Hindlimb Suspension and Clenbuterol in Mature Male Rats
Wineski, L. E., von Deutsch, D. A., Abukhalaf, I. K., Pitts, S., Potter, D. E., & Paulsen, D. F. (2002) · Cells Tissues Organs · doi:10.1159/000063712 · Cited by 36
Sinis, N., Guntinas‐Lichius, O., Irintchev, A., Skouras, E., Küerten, S., Pavlov, S., Schaller, H.-E., Dunlop, S. A., & Angelov, D. N. (2007) · Experimental Brain Research · doi:10.1007/s00221-007-1174-y · Cited by 36
The effects of beta 2-agonists and caffeine on respiratory and limb muscle performance.
Lanigan, C., Howes, T. Q., Borzone, G. R., Vianna, L. G., & Moxham, J. (1993) · PubMed · Cited by 19
Remesar, X., Rafecas, I., Fernández–Löpez, J., & Alemany, M. (1997) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199709)17:5 · Cited by 7
Cited by
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Erdem Büyükkiraz, M., & Kesmen, Z. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15314 · Cited by 454
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Ma, X., Liu, Z., Ilyas, I., Little, P. J., Kamato, D., Sahebka, A., Chen, Z., Luo, S., Zheng, X., Weng, J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59965 · Cited by 299
Franco, E. F., Rana, P., Cruz, A., Calderón, V. V., Azevedo, V., Ramos, R. T. J., & Ghosh, P. (2021) · Cancers · doi:10.3390/cancers13092013 · Cited by 92
The comprehensive landscape of miR-34a in cancer research
Li, S., Wei, X., He, J., Cao, Q., Du, D., Zhan, X., Zeng, Y., Yuan, S., & Sun, L. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09973-3 · Cited by 84
Tylee, D. S., Lee, Y. K., Wendt, F. R., Pathak, G. A., Levey, D. F., De Angelis, F., Gelernter, J., & Polimanti, R. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0914 · Cited by 65
Metadata
- Venue
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos Publications
- Published
- 2026-10-13
- ISSN
- 1792-0981 (ISSN-L)
- 1792-1015
- DOI
- 10.3892/etm
- OpenAlex
- W4200519416
- Cited by
- 1,728
- References
- 20
- Type
- paratext
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
